Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder

Psychiatry Research

Volumn 36, Issue 1, 1991, Pages 1-17

  Hollander, Eric ^a   DeCaria, Concetta ^a   Gully, Robert ^a   Nitescu, Anca ^a   Suckow, Raymond F ^a   Gorman, Jack M ^a   Klein, Donald F ^a   Liebowitz, Michael R ^a  

^a NONE

Author keywords

anxiety disorders; fluoxetine; meta chlorophenylpiperazine; Obsessive compulsive disorder; serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; FLUOXETINE; HYDROCORTISONE; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPULSION; FEMALE; HUMAN; MALE; OBSESSION; PRIORITY JOURNAL;

ADULT; AROUSAL; BRAIN; FEMALE; FLUOXETINE; HUMAN; HYDROCORTISONE; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026035082     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(91)90113-4     Document Type: Article

References (57)

1. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys
2. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels
3. Clomipramine: Prolactin and clinical response
4. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis
5. Elevated antidepressant plasma levels after addition of fluoxetine
6. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats
7. Some pharmacological aspects of desmethylclomipramine
8. Clomipramine in obsessive-compulsive disorder: Further evidence for a serotonergic mechanism of action
9. Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine
10. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami
11. Antagonism of vascular serotonin receptors by m-chlorophenylpiperzine and m-trifluoromethylpiperzine
12. Plasma prolactin concentrations in patients on clomipramine
13. Treatment of obsessive-compulsive disorder with clomipramine
14. Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study
15. Fluoxetine in the treatment of obsessive-compulsive disorder
16. Fluoxetine in the long term maintenance treatment of obsessive-compulsive disorder
17. Dispositions and pharmacological effect of M-CPP in rats
18. Importance of duration of drug action in the antagonism of p-chloramphetamine depletion of brain serotonin: Comparison of fluoxetine and clomiprami
19. Acute effects of atypical antidepressants on various receptors in the rat brain
20. 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain
21. 2 receptor antagonists and 5-HT receptor agonists and antagonists on neuroendocrine function in rhesus monkeys
22. An animal model of depression: The role of serotonin in helpless behavior
23. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings
24. Functional correlates of serotonin 5-HT-1 recognition sites
25. Serotonin-selective antidepressants
26. Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline
27. Effects of m-chlorophenylpiperzine on receptor binding and brain metabolism of monoamines in rats
28. Drug treatment of obsessive-compulsive disorder
29. Fluoxetine treatment of obsessive-compulsive disorder: An open clinical trial
30. Central serotoninmimetic action of phenylpiperazines
31. Clomipramine and exposure for obsessive-compulsive rituals: I
32. Tricyclic antidepressants in obsessive-compulsive disorder: Antiobsessional or antidepressant agents? II
33. Adaptive changes in central serotonin receptors after long-term treatment in rats
34. Clomipramine in obsessional neurosis: A placebo-controlled trial
35. Neuroendocrine effects of m-CPP, a 5HT agonist, in human
36. Further studies of the putative serotonin agonist m-chlorophenylpiperazine Evidence for a serotonin receptor mediated mechanism of action in humans
37. Pharmacological evidence of super-sensitivity of central serotonergic receptors involved in control of prolactin secretion
38. Anafranil (G 34586) in obsessive neurosis
39. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: Comparison with quizapine
40. M-CPP: A central 5HT agonist causing powerful anorexia in rats
41. Neurochemistry of serotonin neuronal systems: Consequences of serotonin receptor activation
42. Fluoxetine: A serotonin-specific, second generation antidepressant
43. Clomipramine: Plasma levels, side effects and outcome in obsessive-compulsive neurosis
44. Clomipramine treatment of obsessive-compulsive disorder: I. A controlled clinical trial
45. Fluoxetine treatment of obsessive-compulsive disorder
46. Different effects of 3-chlorophenylpiperazine on locomotor activity and acquisition of conditioned avoidance response in different strains of mice
47. Clomipramine and imipramine in obsessive-compulsive disorder
48. Receptor alterations associated with serotonergic agents: An autoradiographic analysis
49. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors
50. Chlorimipramine, for obsessive-compulsive neurosis: An organic approach
51. Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology
52. Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment
53. Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls